Literature DB >> 31983249

The lipid raft markers stomatin, prohibitin, flotillin, and HflK/C (SPFH)-domain proteins form an operon with NfeD proteins and function with apolar polyisoprenoid lipids.

Hideshi Yokoyama1, Ikuo Matsui2.   

Abstract

SPFH-domain proteins are found in almost all organisms across three domains: archaea, bacteria, and eukaryotes. In eukaryotic organelles, their subfamilies exhibit overlapping distribution and functions; thus, the rationality of annotation to discriminate these subfamilies remains unclear. In this review, the binding ability of prokaryotic SPFH-domain proteins towards nonpolar polyisoprenoides such as squalene and lycopene, rather than cholesterol, is discussed. The hydrophobic region at the C-terminus of SPFH-domain proteins constitutes the main region that binds apolar polyisoprenoid lipids as well as cholesterol and substantively contributes towards lipid raft formation as these regions are self-assembled together with specific lipids. Because the scaffolding proteins caveolins show common topological properties with SPFH-domain proteins such as stomatin and flotillin, the α-helical segments of stomatin proteins can flexibly move along with the membrane surface, with such movement potentially leading to membrane bending via lipid raft clustering through the formation of high order homo-oligomeric complexes of SPFH-domain proteins. We also discuss the functional significance and ancient origin of SPFH-domain proteins and the NfeD protein (STOPP) operon, which can be traced back to the ancient living cells that diverged and evolved to archaea and bacteria. Based on the molecular mechanism whereby the STOPP-protease degrades the C-terminal hydrophobic clusters of SPFH-domain proteins, it is conceivable that STOPP-protease might control the physicochemical properties of lipid rafts.

Entities:  

Keywords:  NfeD; SPFH (stomatin; SPFH-domain proteins; Stomatin-specific protease; and HflK/C); flotillin; lipid raft; polyisoprenoid lipid; prohibitin

Mesh:

Substances:

Year:  2020        PMID: 31983249     DOI: 10.1080/1040841X.2020.1716682

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  8 in total

1.  [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].

Authors:  J Wang; C Yu; X Jiang; X Wu; Y Jia; H Zhang; Z Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-07-20

2.  Structural insights into the membrane microdomain organization by SPFH family proteins.

Authors:  Chengying Ma; Chengkun Wang; Dingyi Luo; Lu Yan; Wenxian Yang; Ningning Li; Ning Gao
Journal:  Cell Res       Date:  2022-01-03       Impact factor: 46.297

Review 3.  How Does the Spatial Confinement of FtsZ to a Membrane Surface Affect Its Polymerization Properties and Function?

Authors:  Marisela Vélez
Journal:  Front Microbiol       Date:  2022-05-03       Impact factor: 5.640

Review 4.  Recent Advances in Understanding the Structural and Functional Evolution of FtsH Proteases.

Authors:  Lanbo Yi; Bin Liu; Peter J Nixon; Jianfeng Yu; Feng Chen
Journal:  Front Plant Sci       Date:  2022-04-06       Impact factor: 6.627

Review 5.  The lipid rafts in cancer stem cell: a target to eradicate cancer.

Authors:  Shuo Zhang; Neng Zhu; Hong Fang Li; Jia Gu; Chan Juan Zhang; Duan Fang Liao; Li Qin
Journal:  Stem Cell Res Ther       Date:  2022-08-30       Impact factor: 8.079

Review 6.  Function of Platelet Glycosphingolipid Microdomains/Lipid Rafts.

Authors:  Keisuke Komatsuya; Kei Kaneko; Kohji Kasahara
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

7.  UL11 Protein Is a Key Participant of the Duck Plague Virus in Its Life Cycle.

Authors:  Linjiang Yang; Mingshu Wang; Anchun Cheng; Qiao Yang; Ying Wu; Juan Huang; Bin Tian; Renyong Jia; Mafeng Liu; Dekang Zhu; Shun Chen; Xinxin Zhao; Shaqiu Zhang; Xumin Ou; Sai Mao; Qun Gao; Di Sun; Yanlin Yu; Ling Zhang
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640

8.  Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains.

Authors:  Yao Lv; Chu-di Zhang; Yi-Long Wang; Dong-Ming Zhou; Meng-Ying Zhu; Xiao-Qiang Hao; Jin-Hu Wang; Wei-Zhong Gu; Hong-Qiang Shen; Jin-Gan Lou; Ben-Qing Wu; Pei-Chun Chen; Zheng-Yan Zhao
Journal:  Gastric Cancer       Date:  2021-07-12       Impact factor: 7.701

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.